Home : Unsafe Drugs : Avandia : Newsfeeds

Avandia - Newsfeeds

CMAJ calls on federal government to protect Canadians from unsafe drugs
New drugs are often released based on scant understanding of the safety of the drug compounds, which can cause serious health effects and even death, as the examples of rofecoxib (Vioxx) for arthritis, rosiglitazone (Avandia) for diabetes and tegaserod ...
Kanada behöver modernisera sina läkemedel lag, säkerställa läkemedelssäkerhet: CMAJ
Nya läkemedel är ofta frigörs baseras på knappa förståelse för säkerhet läkemedelssubstanser, som kan orsaka allvarliga hälsoeffekter och även död, som exemplen av rofecoxib (Vioxx) för artrit, rosiglitazon (Avandia) för diabetes och ...
Kanada on uudistaa lääketutkimuksen ja lainsäädännön varmistaakseen lääketurvallisuuden: CMAJ
Uudet lääkkeet ovat usein vapautetaan perustuvat niukasti ymmärrystä lääkkeen turvallisuutta yhdisteet, jotka voivat aiheuttaa vakavia terveyshaittoja ja jopa kuoleman, koska esimerkkejä rofekoksibin (Vioxx) niveltulehdus, rosiglitatsonin (Avandia ...
Send this story to a friend
The latest news on the much publicized Avandia Settlement's is: there is no news. After a Bloomberg report made public last summer that many of the Avandia suits were coming to a settlement range of approximately $86,000.00 per suit, no new news
Victoza® Meta-Analysis Shows Greater Blood Sugar Control At All Baseline A1C Levels When Compared To Other Therapies
Victoza® (liraglutide [rDNA origin] injection) 1.8 mg was compared with exenatide, insulin glargine, glimepiride, rosiglitazone, and sitagliptin. Baseline A1C categories included less than or equal to 7.5%, >7.5-8.0%, >8.0-8.5%, >8.5-9.0%, >9.0%.
Victoza® Meta-Analysis Shows Greater Blood Sugar Control at all Baseline A1C Levels When Compared to Other Therapies
Victoza® (liraglutide [rDNA origin] injection) 1.8 mg was compared with exenatide, insulin glargine, glimepiride, rosiglitazone, and sitagliptin.  Baseline A1C categories included less than or equal to 7.5%, >7.5-8.0%, >8.0-8.5%, >8.5-9.0%, >9.0%.
Victoza(R) Meta-Analysis Shows Greater Blood Sugar Control at all Baseline A1C Levels When Compared to Other Therapies
Victoza(R) (liraglutide [rDNA origin] injection) 1.8 mg was compared with exenatide, insulin glargine, glimepiride, rosiglitazone, and sitagliptin. Baseline A1C categories included less than or equal to 7.5%, >7.5-8.0%, >8.0-8.5%, >8.5-9.0%, >9.0%.
Health in short: Long work hours may cause heart problems
Pioglitazone, brand name Actos, belongs to the same class of drugs as the diabetes medication rosiglitazone, sold as Avandia, which was found to increase the risk of heart attack. Use of rosiglitazone has been greatly restricted in the United States.
Agreement With Nealanders International to Market and Distribute CinGx Marks New Milestone for Allegiance Equity Corporation
"After rosiglitazone and other failures, there are no metabolic treatments in sight for AD that are effective and/or do not have serious side effects. Therefore, insulin receptor protein tyrosine kinase treatment for Type 3 Diabetes might represent a new ...
Point-of-Sale Electronic Safety Check May Reduce Heart Attack Risk for Diabetic Patients
Studies suggest rosiglitazone and CIN can put patients at an increased risk for myocardial ischemia, a condition where the arteries in the heart become blocked, thus increasing a person's risk for heart attack. To prevent use of rosiglitazone and CIN ...
Heart risks of diabetes drugs compared
Pioglitazone remains licensed for use in type 2 diabetes, provided that patients meet certain eligibility criteria and that any adverse effects of the drug are monitored. This study was authored by researchers from the University of East Anglia and Johns ...
Senior News Line: More generics mean lower drug prices
Less-expensive generics are sure to follow as competition rises. Drugs set to expire this year and next include: Lipitor (expired in November 2010, generic due this year), Seroquel, Avandia, Lunesta and Singulair. Just before a patent expires, drug ...
Send this story to a friend
According to a new pharmacy benefit study, a point-of-sale automated electronic safety edit, designed to require provider prior authorization for members who have a rosiglitazone claim with concurrent use of insulin or nitrate , potentially
Avandia Lawsuit Settlement News: 'No News is Bad News,' Says Plaintiffs First Quarter Comes and Goes Without Final Settlement Figures
NEW YORK, April 5, 2011 /PRNewswire via COMTEX/ -- The latest news on the much publicized Avandia Settlement's is: there is no news. After a Bloomberg report made public last summer that many of the Avandia suits were coming to a settlement range of ...
S.B. 5 puts Ohio in national spotlight
Senate Bill 5 — passed by the Republican legislature and signed into law by Gov. John Kasich — might end up on the Nov. 8 ballot as a referendum. Opponents want voters to decide whether public employees should have collective bargaining rights ...
Avandia Lawsuit Settlement News: 'No News is Bad News,' Says Plaintiffs
NEW YORK , April 5, 2011 /PRNewswire/ -- The latest news on the much publicized Avandia Settlement's is: there is no news.  After a Bloomberg report made public last summer that many of the Avandia suits were coming to a settlement range of approximately ...
Point-of-Sale Electronic Safety Check May Reduce Heart Attack Risk for Diabetic Patients
by Prime Therapeutics (Prime), a thought leader in pharmacy benefit management. Rosiglitazone, also known under its brand name Avandia®, is an antidiabetic drug therapy (ADT) designed to help control blood sugar in patients with Type 2 diabetes mellitus.
Optimal Treatment Outlined for Patients with Heart Failure and Serious Comorbidities, Including "Diabesity"
NEW ORLEANS , LA —Investigators at the forefront of treating the patient with heart failure (HF) and concomitant diabetes, obesity, depression, sleep apnea, left ventricular (LV) hypertrophy or renal insufficiency presented the latest management findings ...
In Elderly Hypertensive Patients, Combination ARB and Calcium Channel Blocker Produces Similar Outcomes to High-Dose ARB Alone
NEW ORLEANS, LA --Elderly patients with hypertension have similar rates of cardiovascular events and death when treated with a combination of an angiotensin II receptor blocker (ARB) and a calcium channel blocker (CCB) compared to high-dose ARB alone ...
Some diabetes drugs are better than others, according to new study
New research suggests that several commonly prescribed drugs for type 2 diabetes may not be as effective at preventing death and cardiovascular diseases, such as heart attacks and stroke, as the oral anti-diabetic drug, metformin. Compared to metformin ...
Do you need an Avandia attorney in Washington, DC? Contact one of our Avandia attorneys in Washington, DC now.

Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.

Pages: Previous   1   2   3   4   5   6   7   8   9   10   ...   Next

Avandia Case Evaluation Form

This form is secure and encrypted. More information about secure forms and your privacy here.

YOUR CONTACT INFORMATION
First Name: *
Last Name: *
E-mail Address: *
Address:
City:
State: *
Zipcode:
Phone: -- xtn

CASE INFORMATION
Why Was Avandia Prescribed?: *
What Dosage, in Milligrams?:
How Frequently Was Avandia Taken?:
Date Patient Began Taking Avandia:

Stopped Taking Avandia:

What Symptoms Were Experienced?: *
Heart Attack
Stroke
Heart Failure

 Death
Other
PPH
If "Other", Please Describe:
How Long Was it From the Last Dose to the Problems Appearing?:
    Within 1 Day 2 Days 3 Days
    More Than 3 Days Don't Know
Questions/Comments:

Need An Avandia Attorney?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


Do you need an Avandia attorney in Washington, DC? Contact one of our Avandia attorneys in Washington, DC now.

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Avandia Case - Submit Your Information Below

Do you need legal assistance with your Avandia case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

YOUR CONTACT INFORMATION
First Name: *
Last Name: *
E-mail Address: *
Address:
City:
State: *
Zipcode:
Phone: -- xtn

CASE INFORMATION
Why Was Avandia Prescribed?: *
What Dosage, in Milligrams?:
How Frequently Was Avandia Taken?:
Date Patient Began Taking Avandia:

Stopped Taking Avandia:

What Symptoms Were Experienced?: *
Heart Attack
Stroke
Heart Failure

 Death
Other
PPH
If "Other", Please Describe:
How Long Was it From the Last Dose to the Problems Appearing?:
    Within 1 Day 2 Days 3 Days
    More Than 3 Days Don't Know
Questions/Comments:
This form is secure and encrypted. More information about secure forms and your privacy here.